$102.46 -0.85 (%) Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Apr. 17, 2015 | 04:00 PM

Partner Headlines

  1. Amgen's First Drug For Cardiovascular Disease Gets The Green Light

    GuruFocus | Apr. 17, 2015 | 22:41PM EST
  2. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  3. Mylan Scores Final Win In Patent Challenge On Inhalation Drug

    Benzinga | Apr. 17, 2015 | 14:27PM EST
  4. Momenta, Novartis get FDA OK

    IBD | Apr. 16, 2015 | 18:43PM EST
  5. Momenta, Novartis Win FDA Nod For Generic Copaxone

    IBD | Apr. 16, 2015 | 14:39PM EST
  6. Receptos MS Drug Succeeds Against Ulcerative Colitis

    IBD | Apr. 16, 2015 | 10:50AM EST
  7. Biotech IPOs Ignite As Aduro Doubles On First Day

    IBD | Apr. 15, 2015 | 13:57PM EST
  8. Pfizer, Biogen, AbbVie Get Good Drug-Trial News

    IBD | Apr. 15, 2015 | 11:49AM EST
  9. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD | Apr. 14, 2015 | 14:37PM EST
  10. Benzinga's M&A Chatter for Wednesday February 25, 2015

    Benzinga | Feb. 25, 2015 | 21:26PM EST
  11. Pharmacyclics hits new high

    IBD | Feb. 25, 2015 | 18:51PM EST
  12. Deutsche Bank On Pharmacyclics: 'We Do Not See Much Upside'

    Benzinga | Feb. 25, 2015 | 17:05PM EST
  13. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  14. United Therapeutics Blood Pressure Drug Spurs Q4 Beat

    IBD | Feb. 24, 2015 | 10:04AM EST
  15. Hot Income Stocks: Who's Growing Dividends The Fastest?

    IBD | Feb. 23, 2015 | 16:49PM EST
  16. Can These Three BioTech Companies Make It Big?

    GuruFocus | Feb. 20, 2015 | 15:22PM EST
  17. Can Veeva Systems' Software Keep Luring Big Pharma?

    IBD | Feb. 17, 2015 | 13:26PM EST
  18. Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

    Benzinga | Feb. 13, 2015 | 15:32PM EST
  19. The Reasons That Make Pfizer A Worthy Hold.

    GuruFocus | Feb. 5, 2015 | 11:19AM EST
  20. Credit Suisse Adds 10 Names To European 'Top Picks'

    Benzinga | Feb. 5, 2015 | 07:48AM EST
  21. Stocks That Battle Cancer Were The Best-Performing Biotechs In January

    Benzinga | Jan. 30, 2015 | 13:03PM EST
  22. Valeant Agrees To Buy Dendreon's Provenge

    IBD | Jan. 30, 2015 | 11:39AM EST
  23. Drugmakers Warn On Dollar

    IBD | Jan. 27, 2015 | 18:47PM EST
  24. Strong Dollar Pins U.S. Corporate Earnings Outlook

    IBD | Jan. 27, 2015 | 18:29PM EST
  25. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  26. Strong Dollar Means Flabby Outlook For Some Overseas

    IBD | Jan. 27, 2015 | 13:45PM EST
  27. Bristol, Pfizer, Novartis Forecasts Face FX Pressures

    IBD | Jan. 27, 2015 | 11:57AM EST
  28. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 27, 2015 | 08:13AM EST
  29. Novartis Posts Drop In Q4 Net Profit

    Benzinga | Jan. 27, 2015 | 04:58AM EST
  30. Earnings Scheduled For January 27, 2015

    Benzinga | Jan. 27, 2015 | 04:34AM EST
  31. Lannett Early Q2 Earnings Beat Estimates; Stock Jumps

    IBD | Jan. 26, 2015 | 12:20PM EST
  32. Trio Of Wall Street Firms Up Array BioPharma Price Targets

    Benzinga | Jan. 26, 2015 | 10:05AM EST
  33. Can CAR-T Therapy Live Up To The Biotech IPO Hype?

    IBD | Jan. 26, 2015 | 08:02AM EST
  34. Benzinga's Weekend M&A Chatter

    Benzinga | Jan. 25, 2015 | 18:50PM EST
  35. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  36. Why Shares Of Array Biopharma Are Surging More Than 35%

    Benzinga | Jan. 23, 2015 | 11:52AM EST
  37. Johnson & Johnson Riding High On Ebola Vaccines

    GuruFocus | Jan. 21, 2015 | 11:46AM EST
  38. United Therapeutics Clears Hypertension Drug Hurdles

    IBD | Jan. 16, 2015 | 18:44PM EST
  39. Watchmakers Caught In The #Francogeddon Storm

    Benzinga | Jan. 16, 2015 | 14:39PM EST
  40. Swiss Stop Defending Franc

    IBD | Jan. 15, 2015 | 18:52PM EST
  41. 3 Reasons To Be Bullish On Generic Drug Firm Akorn

    IBD | Jan. 15, 2015 | 14:12PM EST
  42. Benzinga's Volume Movers

    Benzinga | Jan. 15, 2015 | 10:40AM EST
  43. Swiss ADRs Gain Big As Swiss National Bank Surprises With Currency Revaluation

    Benzinga | Jan. 15, 2015 | 10:07AM EST
  44. Drugs May Be Blockbusters

    IBD | Jan. 8, 2015 | 18:54PM EST
  45. Can India Stocks Top Most World Markets This Year?

    IBD | Jan. 8, 2015 | 18:29PM EST
  46. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  47. US Stock Futures Jump Ahead Of Jobless Claims

    Benzinga | Jan. 8, 2015 | 07:00AM EST
  48. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD | Jan. 5, 2015 | 18:20PM EST
  49. Kite Pharma Up On Amgen Cancer Parternship

    IBD | Jan. 5, 2015 | 11:49AM EST
  50. Benzinga's Top Upgrades

    Benzinga | Jan. 5, 2015 | 08:34AM EST
Trading Center